Search
Learn about dense breast tissue and what it means for your cancer risk and screening needs.
Nearly two thirds of patients who were treated with the combination enfortumab vedotin plus pembrolizumab saw their tumors shrink.
Physicians and scientists from Memorial Sloan Kettering Cancer Center (MSK) will join oncology experts and members of the global cancer research community to present the latest advances in cancer discovery during the American Association for Cancer Research (AACR) Annual Meeting on April 5-10 in San Diego, California.
Physicians and scientists from Memorial Sloan Kettering Cancer Center (MSK) will join oncology experts and members of the global cancer research community to present the latest advances in cancer during the American Association for Cancer Research (AACR) Annual Meeting on April 14-19 in Orlando, Florida.
Researchers from Memorial Sloan Kettering Cancer Center to present the latest advances in blood cancer during The American Society of Hematology 2024 annual meeting.
Memorial Sloan Kettering Cancer Center (MSK) is pleased to announce Eileen M. O’Reilly, MD; Howard I. Scher, MD; and Deb Schrag, MD, MPH, have been elected to the 11th class of Giants of Cancer Care® for their contributions to gastrointestinal cancer care, genitourinary cancer care, and prevention and care delivery respectively.
Memorial Sloan Kettering Cancer Center (MSK) is pleased to announce three faculty are among the 23 international scientific leaders elected today to the prestigious Fellows of the American Association for Cancer Research (AACR) Academy class of 2023. All three are members of the Sloan Kettering Institute, a hub for basic science and translational research within MSK.
On World Cancer Day, MSK Launches Public-Service Announcement ‘Late,’ Emphasizing the Urgency and Power of Routine Cancer Screenings
Memorial Sloan Kettering Cancer Center (MSK) is pleased to announce Selwyn M. Vickers, MD, President and CEO of MSK, is among 30 international scientific leaders elected today to the prestigious Fellows of the American Association for Cancer Research (AACR) Academy class of 2024.
Sloan Kettering Institute’s (SKI) Alexander Gitlin, MD, PhD of Memorial Sloan Kettering Cancer Center (MSK) was recognized as a winner of the National Institutes of Health (NIH) Director’s Early Independence Award.